Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biotools B&M Labs is a Spanish biotechnology company focused on molecular biology reagents, PCR kits, diagnostic kits, recombinant enzymes, and related research tools for life sciences and clinical laboratory use. The company serves biomedicine, biotechnology, and life science customers rather than operating as a therapeutics developer with a conventional drug pipeline. Its product portfolio has been described as spanning molecular biology, genomics, proteomics, pathogen detection, and microarray applications. Available secondary sources indicate the business was founded in 1996 in Madrid and was later acquired by Laboratorios Inibsa while continuing to operate under the Biotools name. Overall, it appears to be a commercial-stage life science tools and molecular diagnostics company with manufacturing and OEM/customization capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biotools B&M Labs.